DOCSLIB.ORG

21 CFR Ch. II (4–1–12 Edition) § 1308.12

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
21 CFR Ch. II (4–1–12 Edition) § 1308.12 § 1308.12 21 CFR Ch. II (4–1–12 Edition) § 1308.12 Schedule II. stances, except that the substances (a) Schedule II shall consist of the shall not include decocainized coca drugs and other substances, by what- leaves or extraction of coca leaves, ever official name, common or usual which extractions do not contain co- name, chemical name, or brand name caine or ecgonine. (5) Concentrate of poppy straw (the designated, listed in this section. Each crude extract of poppy straw in either drug or substance has been assigned liquid, solid or powder form which con- the Controlled Substances Code Num- tains the phenanthrene alkaloids of the ber set forth opposite it. opium poppy), 9670. (b) Substances, vegetable origin or (c) Opiates. Unless specifically ex- chemical synthesis. Unless specifically cepted or unless in another schedule excepted or unless listed in another any of the following opiates, including schedule, any of the following sub- its isomers, esters, ethers, salts and stances whether produced directly or salts of isomers, esters and ethers indirectly by extraction from sub- whenever the existence of such iso- stances of vegetable origin, or inde- mers, esters, ethers, and salts is pos- pendently by means of chemical syn- sible within the specific chemical des- thesis, or by a combination of extrac- ignation, dextrorphan and tion and chemical synthesis: levopropoxyphene excepted: (1) Opium and opiate, and any salt, (1) Alfentanil ................................................................... 9737 compound, derivative, or preparation (2) Alphaprodine ............................................................ 9010 of opium or opiate excluding (3) Anileridine ................................................................. 9020 apomorphine, thebaine-derived (4) Bezitramide .............................................................. 9800 (5) Bulk dextropropoxyphene (non-dosage forms) ........ 9273 butorphanol, dextrorphan, nalbuphine, (6) Carfentanil ................................................................ 9743 nalmefene, naloxone, and naltrexone, (7) Dihydrocodeine ........................................................ 9120 and their respective salts, but includ- (8) Diphenoxylate ........................................................... 9170 (9) Fentanyl .................................................................... 9801 ing the following: (10) Isomethadone ......................................................... 9226 (i) Codeine ..................................................................... 9050 (11) Levo-alphacetylmethadol ....................................... 9648 (ii) Dihydroetorphine ...................................................... 9334 [Some other names: levo-alpha-acetylmethadol, (iii) Ethylmorphine .......................................................... 9190 levomethadyl acetate, LAAM] (iv) Etorphine hydrochloride ........................................... 9059 (12) Levomethorphan .................................................... 9210 (v) Granulated opium ..................................................... 9640 (13) Levorphanol ............................................................ 9220 (vi) Hydrocodone ........................................................... 9193 (14) Metazocine ............................................................. 9240 (vii) Hydromorphone ...................................................... 9150 (15) Methadone ............................................................. 9250 (viii) Metopon ................................................................. 9260 (16) Methadone-Intermediate, 4-cyano-2- (ix) Morphine .................................................................. 9300 dimethylamino-4,4-diphenyl butane ........................... 9254 (x) Opium extracts ......................................................... 9610 (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, (xi) Opium fluid .............................................................. 9620 1-diphenylpropane-carboxylic acid ............................. 9802 (xii) Oripavine ................................................................. 9330 (18) Pethidine (meperidine) ........................................... 9230 (xiii) Oxycodone ............................................................. 9143 (19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4- (xiv) Oxymorphone ........................................................ 9652 phenylpiperidine ......................................................... 9232 (xv) Powdered opium ..................................................... 9639 (20) Pethidine-Intermediate-B, ethyl-4- (xvi) Raw opium ............................................................. 9600 phenylpiperidine-4-carboxylate .................................. 9233 (xvii) Thebaine ............................................................... 9333 (21) Pethidine-Intermediate-C, 1-methyl-4- (xviii) Tincture of opium ................................................. 9630 phenylpiperidine-4-carboxylic acid ............................. 9234 (22) Phenazocine ........................................................... 9715 (2) Any salt, compound, derivative, or (23) Piminodine .............................................................. 9730 preparation thereof which is chemi- (24) Racemethorphan .................................................... 9732 (25) Racemorphan ......................................................... 9733 cally equivalent or identical with any (26) Remifentanil ........................................................... 9739 of the substances referred to in para- (27) Sufentanil ............................................................... 9740 graph (b) (1) of this section, except that (28) Tapentadol ............................................................. 9780 these substances shall not include the (d) Stimulants. Unless specifically ex- isoquinoline alkaloids of opium. cepted or unless listed in another (3) Opium poppy and poppy straw. schedule, any material, compound, (4) Coca leaves (9040) and any salt, mixture, or preparation which contains compound, derivative or preparation of any quantity of the following sub- coca leaves (including cocaine (9041) stances having a stimulant effect on and ecgonine (9180) and their salts, iso- the central nervous system: mers, derivatives and salts of isomers (1) Amphetamine, its salts, optical isomers, and salts and derivatives), and any salt, com- of its optical isomers .................................................. 1100 pound, derivative, or preparation (2) Methamphetamine, its salts, isomers, and salts of its isomers .................................................................. 1105 thereof which is chemically equivalent (3) Phenmetrazine and its salts ..................................... 1631 or identical with any of these sub- (4) Methylphenidate ....................................................... 1724 108 VerDate Mar<15>2010 14:42 May 17, 2012 Jkt 226075 PO 00000 Frm 00118 Fmt 8010 Sfmt 8010 Y:\SGML\226075.XXX 226075 pmangrum on DSK3VPTVN1PROD with CFR Drug Enforcement Administration, Justice § 1308.13 (5) Lisdexamfetamine, its salts, isomers, and salts of the DEA Controlled Substances Code its isomers .................................................................. 1205 Number set forth opposite it. (e) Depressants. Unless specifically (b) Stimulants. Unless specifically ex- excepted or unless listed in another cepted or unless listed in another schedule, any material, compound, schedule, any material, compound, mixture, or preparation which contains mixture, or preparation which contains any quantity of the following sub- any quantity of the following sub- stances having a depressant effect on stances having a stimulant effect on the central nervous system, including the central nervous system, including its salts, isomers, and salts of isomers its salts, isomers (whether optical, po- whenever the existence of such salts, sitional, or geometric), and salts of isomers, and salts of isomers is possible such isomers whenever the existence of within the specific chemical designa- such salts, isomers, and salts of iso- tion: mers is possible within the specific (1) Amobarbital .............................................................. 2125 chemical designation: (2) Glutethimide ............................................................. 2550 (1) Those compounds, mixtures, or preparations in (3) Pentobarbital ............................................................ 2270 dosage unit form containing any stimulant sub- (4) Phencyclidine ........................................................... 7471 stances listed in schedule II which compounds, mix- (5) Secobarbital ............................................................. 2315 tures, or preparations were listed on August 25, 1971, as excepted compounds under § 1308.32, and (f) Hallucinogenic substances. any other drug of the quantitative composition (1) Nabilone ................................................................... 7379 shown in that list for those drugs or which is the [Another name for nabilone: (±)-trans-3-(1,1- same except that it contains a lesser quantity of dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hy- controlled substances ................................................ 1405 droxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one] (2) Benzphetamine ........................................................ 1228 (3) Chlorphentermine ....................................................
Load more

Recommended publications
  • Screening/Spot Test of Narcotics
    Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Introduced B.,Byhansen, 16
    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
    [Show full text]
  • Order in Council 1243/1995
    PROVINCE OF BRITISH COLUMBIA ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL Order in Council No. 12 4 3 , Approved and Ordered OCT 121995 Lieutenant Governor Executive Council Chambers, Victoria On the recommendation of the undersigned, the Lieutenant Governor, by and with the advice and consent of the Executive Council, orders that Order in Council 1039 made August 17, 1995, is rescinded. 2. The Drug Schedules made by regulation of the Council of the College of Pharmacists of British Columbia, as set out in the attached resolution dated September 6, 1995, are hereby approved. (----, c" g/J1"----c- 4- Minister of Heal fandand Minister Responsible for Seniors Presidin Member of the Executive Council (This pan is for adnwustratlye purposes only and is not part of the Order) Authority under which Order Is made: Act and section:- Pharmacists, Pharmacy Operations and Drug Scheduling Act, section 59(2)(1), 62 Other (specify): - Uppodukoic1enact N6145; Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made by teleconference at Vancouver, British Columbia, the 6th day of September 1995. RESOLVED THAT: In accordance with the authority established in Section 62 of the Pharmacists, Pharmacy Operations and Drug Scheduling Act of British Columbia, S.B.C. Chapter 62, the Council makes the Drug Schedules by regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy Linda J. Lytle, Phr.) Registrar DRUG SCHEDULES to the Pharmacists, Pharmacy Operations and Drug Scheduling Act of British Columbia The Drug Schedules have been printed in an alphabetical format to simplify the process of locating each individual drug entry and determining its status in British Columbia.
    [Show full text]
  • Laws and Rules Related to the Practice of Pharmacy in South Dakota
    Laws and Rules Related to the Practice of Pharmacy in South Dakota October 12, 2020 South Dakota Board of Pharmacy 4001 W. Valhalla Blvd, Ste 106 Sioux Falls, SD 57106 P – 605.362.2737 F – 605.362.2738 W – pharmacy.sd.gov E - [email protected] This page intentionally left blank Contents SDCL Chapter 36-11 Pharmacies and Pharmacists ARSD 20:51 Pharmacists SDCL Chapter 36-11A Wholesale & Other Drug Distributors ARSD 20:67 Wholesale & Other Drug Distributors SDCL Chapter 34-20B Drugs and Substances Control SDCL Chapter 34-20D Products Containing Pseudoephedrine, Ephedrine, or Phenylpropanolamine SDCL Chapter 34-20E Prescription Drug Monitoring Program ARSD 44:58 Drug Control SDCL Chapter 34-12B Nursing Facility Pharmacies ARSD 44:73:08 Medication Control Nursing Facilities ARSD 44:75:08 Medication Control Hospital ARSD 44:75:14:11 Pharmacy or Drug Room SDCL Chapter 36-2A Health Professionals Assistance Program SDCL Chapter 34-20A Treatment and Prevention of Alcohol and Drug Abuse Disclaimer for use with authorization to reprint the code. Current statement. COPYRIGHT © 1967-2015 BY THE STATE OF SOUTH DAKOTA, REPRINTED BY PERMISSION The laws contained in this pamphlet are reprinted with the permission of the Code Commission. You are advised that the legislature amends these laws from time to time and that the laws contained here may be superseded by acts of the legislature. The current session laws and the codified laws of the State supersede any law that is in conflict with a law published in this pamphlet. This page intentionally left blank CHAPTER 36-11 PHARMACIES AND PHARMACISTS 36-11-1 Public interest in regulation of practice.
    [Show full text]
  • Senate Bill 1088
    Senate Engrossed controlled substances; schedule designations State of Arizona Senate Fifty-fifth Legislature First Regular Session 2021 CHAPTER 61 SENATE BILL 1088 AN ACT AMENDING SECTIONS 13-3412, 13-3412.01, 13-3451, 32-1401, 32-1501, 32-1901, 32-1969, 32-2901, 32-2933, 36-2501, 36-2511, 36-2512, 36-2513, 36-2514, 36-2515, 36-2516, ARIZONA REVISED STATUTES; AMENDING TITLE 36, CHAPTER 27, ARTICLE 2, ARIZONA REVISED STATUTES, BY ADDING SECTION 36-2518; AMENDING SECTIONS 36-2525, 36-2531 AND 36-2608, ARIZONA REVISED STATUTES; RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT. (TEXT OF BILL BEGINS ON NEXT PAGE) - i - S.B. 1088 1 Be it enacted by the Legislature of the State of Arizona: 2 Section 1. Section 13-3412, Arizona Revised Statutes, is amended to 3 read: 4 13-3412. Exceptions and exemptions; burden of proof; 5 privileged communications 6 A. The provisions of sections 13-3402 and 13-3403, section 7 13-3404.01, subsection A, paragraph 1 and sections 13-3405 through 13-3409 8 do not apply to: 9 1. Manufacturers, wholesalers, pharmacies and pharmacists under the 10 provisions of sections 32-1921 and 32-1961. 11 2. Medical practitioners, pharmacies and pharmacists while acting 12 in the course of their professional practice, in good faith and in 13 accordance with generally accepted medical standards. 14 3. Persons who lawfully acquire and use such drugs only for 15 scientific purposes. 16 4. Officers and employees of the United States, this state or a 17 political subdivision of the United States or this state, while acting in 18 the course of their official duties.
    [Show full text]
  • 3713S.03F Senate Substitute
    3713S.03F SENATE SUBSTITUTE FOR SENATE COMMITTEE SUBSTITUTE FOR SENATE BILL NO. 523 AN ACT To repeal sections 195.015, 195.017, 579.065, and 579.068, RSMo, and to enact in lieu thereof five new sections relating to controlled substances, with existing penalty provisions. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF MISSOURI, AS FOLLOWS: 1 Section A. Sections 195.015, 195.017, 579.065, and 579.068, 2 RSMo, are repealed and five new sections enacted in lieu thereof, 3 to be known as sections 195.015, 195.017, 195.805, 579.065, and 4 579.068, to read as follows: 5 195.015. 1. The department of health and senior services 6 shall administer this chapter and may add substances to the 7 schedules after public notice and hearing. In making a 8 determination regarding a substance, the department of health and 9 senior services shall consider the following: 10 (1) The actual or relative potential for abuse; 11 (2) The scientific evidence of its pharmacological effect, 12 if known; 13 (3) The state of current scientific knowledge regarding the 14 substance; 15 (4) The history and current pattern of abuse; 16 (5) The scope, duration, and significance of abuse; 1 1 (6) The risk to the public health; 2 (7) The potential of the substance to produce psychic or 3 physiological dependence liability; and 4 (8) Whether the substance is an immediate precursor of a 5 substance already controlled under this chapter. 6 2. After considering the factors enumerated in subsection 1 7 of this section the department of health and senior services 8 shall make findings with respect thereto and issue a rule 9 controlling the substance if it finds the substance has a 10 potential for abuse.
    [Show full text]
  • Laws 2021, LB236, § 4
    LB236 LB236 2021 2021 LEGISLATIVE BILL 236 Approved by the Governor May 26, 2021 Introduced by Brewer, 43; Clements, 2; Erdman, 47; Slama, 1; Lindstrom, 18; Murman, 38; Halloran, 33; Hansen, B., 16; McDonnell, 5; Briese, 41; Lowe, 37; Groene, 42; Sanders, 45; Bostelman, 23; Albrecht, 17; Dorn, 30; Linehan, 39; Friesen, 34; Aguilar, 35; Gragert, 40; Kolterman, 24; Williams, 36; Brandt, 32. A BILL FOR AN ACT relating to law; to amend sections 28-1202 and 69-2436, Reissue Revised Statutes of Nebraska, and sections 28-401 and 28-405, Revised Statutes Cumulative Supplement, 2020; to redefine terms, change drug schedules, and adopt federal drug provisions under the Uniform Controlled Substances Act; to provide an exception to the offense of carrying a concealed weapon as prescribed; to define a term; to change provisions relating to renewal of a permit to carry a concealed handgun; to provide a duty for the Nebraska State Patrol; to eliminate an obsolete provision; to harmonize provisions; and to repeal the original sections. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2020, is amended to read: 28-401 As used in the Uniform Controlled Substances Act, unless the context otherwise requires: (1) Administer means to directly apply a controlled substance by injection, inhalation, ingestion, or any other means to the body of a patient or research subject; (2) Agent means an authorized person who acts on behalf of or at the direction of another person but does not include a common or contract carrier, public warehouse keeper, or employee of a carrier or warehouse keeper; (3) Administration means the Drug Enforcement Administration of the United States Department of Justice; (4) Controlled substance means a drug, biological, substance, or immediate precursor in Schedules I through V of section 28-405.
    [Show full text]
  • HHHHHHHHIIII USOO5290775A United States Patent (19) 11) Patent Number: 5,290,775 Sawyer Et Al
    HHHHHHHHIIII USOO5290775A United States Patent (19) 11) Patent Number: 5,290,775 Sawyer et al. (45) Date of Patent: Mar. 1, 1994 (54) EUTHANASIA COMPOSITIONS Tona et al., European Journal of Pharmacology, 178, 293-301 (1990). 75) Inventors: Donald C. Sawyer, Okemos; Marlee Dialog Acc. No.: 01999557, American Hospital For A. Langham, DeWitt; Theodore M. mula Y Service; Monograph Title: Quinacrine Hydro Brody, East Lansing, all of Mich. chloride, 1991. 73 Assignee: Board of Trustees operating Michigan Mudge, Goodman and Gilman eds., pp. 866-874, 1985. State University, East Lansing, Mich. CA 106(7):43892s, Nath et al., 1986. CA 103(21):171845d, Dallaire et al., 1985. (21) Appl. No.: 709,193 Don Michael et al., Am. Heart J., 79(6), 1970, pp. 831-842. (22) Filed: Jun. 3, 1991 Mudge, G. H. and Weiner, I.M., Water, Salts and Ions. In Goodman and Gilman's The Pharmacological Basis Related U.S. Application Data of Therapeutics, Gilman, Rall, Nies and Taylor, Ed., 63) Continuation-in-part of Ser. No. 631,090, Dec. 19, New York, p. 846, Pergamon Press, Inc. (1990). 1990. Primary Examiner-Frederick E. Waddell 51) Int. Cl. ..................... A61K 31/54; A61K 31/44; Assistant Examiner-Kimberly R. Jordan A61K 31/47; A61K 31/16 Attorney, Agent, or Firm-Ian C. McLeod 52) U.S. C. ................................. 514/224.8; 514/289; 57 ABSTRACT 514/296; 514/313; 514/626; 514/629; 514/630 An euthanasia solution based upon gamma-hydroxybu 58) Field of Search ..................... 514/224.8, 289, 296, tramide, a cardiotoxic amount of a compound selected 514/313, 626, 629, 630 from a chloroquine and quinacrine compound and lido (56) References Cited caine as a base or as a water soluble salt is described.
    [Show full text]